Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China
· Delayed Price · Currency is CNY 11.95
-0.23 (-1.89%)
Mar 11, 2026, 11:34 AM CST
SHE:002900 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,770 | 3,049 | 4,228 | 4,229 | 6,453 | 2,866 | Upgrade
|
| Market Cap Growth | 19.53% | -27.88% | -0.01% | -34.47% | 125.19% | -22.59% | Upgrade
|
| Enterprise Value | 4,078 | 3,126 | 3,815 | 3,675 | 6,009 | 2,152 | Upgrade
|
| Last Close Price | 12.18 | 9.71 | 13.19 | 13.09 | 19.47 | 8.62 | Upgrade
|
| PE Ratio | - | 51.97 | 57.40 | 139.99 | 18.39 | 97.72 | Upgrade
|
| Forward PE | - | 40.26 | 40.26 | 40.26 | 40.26 | 40.26 | Upgrade
|
| PS Ratio | 4.31 | 2.69 | 3.56 | 4.11 | 6.82 | 2.14 | Upgrade
|
| PB Ratio | 1.98 | 1.41 | 1.97 | 2.06 | 3.05 | 1.60 | Upgrade
|
| P/TBV Ratio | 2.12 | 1.49 | 2.09 | 2.14 | 3.18 | 1.69 | Upgrade
|
| P/FCF Ratio | - | - | - | 76.30 | - | - | Upgrade
|
| P/OCF Ratio | 36.44 | 99.37 | 118.45 | 29.24 | - | - | Upgrade
|
| EV/Sales Ratio | 4.66 | 2.76 | 3.22 | 3.57 | 6.35 | 1.61 | Upgrade
|
| EV/EBITDA Ratio | - | 23.47 | 42.19 | 56.52 | - | 32.78 | Upgrade
|
| EV/EBIT Ratio | - | 95.56 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -30.96 | - | - | 66.31 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.43 | 0.33 | 0.32 | 0.23 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | - | 6.51 | 7.13 | 8.80 | - | 4.11 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 11.85 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.04 | -0.15 | -0.31 | -0.29 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.60 | 0.70 | -3.65 | -9.80 | 10.36 | -11.46 | Upgrade
|
| Net Debt / FCF Ratio | -2.32 | -0.30 | 1.25 | -11.50 | 7.21 | 5.00 | Upgrade
|
| Asset Turnover | 0.24 | 0.31 | 0.35 | 0.32 | 0.34 | 0.52 | Upgrade
|
| Inventory Turnover | 1.91 | 2.15 | 2.57 | 2.27 | 1.82 | 2.43 | Upgrade
|
| Quick Ratio | 0.69 | 0.86 | 1.36 | 2.38 | 2.32 | 2.01 | Upgrade
|
| Current Ratio | 0.97 | 1.17 | 1.70 | 2.72 | 2.66 | 2.45 | Upgrade
|
| Return on Equity (ROE) | -9.58% | 2.55% | 3.34% | 1.27% | 17.89% | 1.46% | Upgrade
|
| Return on Assets (ROA) | -2.73% | 0.56% | -0.15% | -0.63% | -3.38% | -0.35% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.01% | 1.47% | -0.43% | -1.45% | -9.15% | -1.22% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.60% | 1.30% | -0.30% | -1.20% | -5.90% | -0.80% | Upgrade
|
| Earnings Yield | -5.06% | 1.92% | 1.74% | 0.71% | 5.44% | 1.02% | Upgrade
|
| FCF Yield | -3.49% | -10.35% | -6.24% | 1.31% | -1.34% | -5.25% | Upgrade
|
| Dividend Yield | 1.67% | 2.06% | 1.52% | 0.76% | 1.64% | 0.93% | Upgrade
|
| Payout Ratio | - | 178.20% | 55.71% | 361.96% | 9.78% | 326.66% | Upgrade
|
| Buyback Yield / Dilution | -2.72% | -0.61% | -1.61% | 2.74% | 4.68% | -4.82% | Upgrade
|
| Total Shareholder Return | -1.05% | 1.44% | -0.09% | 3.50% | 6.33% | -3.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.